<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03182946</url>
  </required_header>
  <id_info>
    <org_study_id>08-16-22E</org_study_id>
    <nct_id>NCT03182946</nct_id>
  </id_info>
  <brief_title>Correcting Platelet Dysfunction After Traumatic Brain Injury</brief_title>
  <official_title>Correction of Platelet Dysfunction Following Traumatic Brain Injury in Geriatric Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Carolinas Healthcare System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Carolinas Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Carolinas Healthcare System</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the impact of platelet transfusion on geriatric patients with platelet
      dysfunction from Traumatic Brain Injury. The authors hypothesize that patients will recover
      better if their platelet dysfunction is corrected with platelet transfusion.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The geriatric population is subject to traumatic brain injury, often occurring as a result of
      falls. This patient population is also often receiving anticoagulants and platelet inhibitors
      increasing their risk of post-injury hemorrhage. Following Traumatic Brain Injury, even
      without platelet inhibitor medications, platelets become dysfunctional and are no longer able
      to assist with clot formation. Therefore risk of hemorrhage is increased, both in the brain,
      and other hemorrhagic sites. Clinical practice at Carolinas Medical Center is to transfuse
      platelets in patients with platelet dysfunction following brain injury. The current study is
      investigating the impact of transfusion on correction of platelet dysfunction and patient
      outcome.

      Furthermore, stored platelet dysfunction can be corrected by supplementation with cytochrome
      c, which supports mitochondrial function. Therefore, the ability of cytochrome c to correct
      dysfunction in ex vivo platelets from patients with Traumatic Brain Injury will be assessed.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 19, 2017</start_date>
  <completion_date type="Anticipated">June 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in platelet function</measure>
    <time_frame>Within 5 hours</time_frame>
    <description>Correction of platelet inhibition measured before and after transfusion through platelet mapping thromboelastography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>1-3 months</time_frame>
    <description>Mortality will be compared to admission platelet inhibition</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional Independence Measure</measure>
    <time_frame>6-12 months</time_frame>
    <description>Patient function as measured by Functional Independence Measure compared to platelet inhibition</description>
  </secondary_outcome>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Platelet Dysfunction</condition>
  <condition>Traumatic Brain Injury</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Platelet mapping Thromboelastography</intervention_name>
    <description>These diagnostic tests will be acquired in patients with brain injury, to determine prediction of clinical, functional and psychological outcome.</description>
    <other_name>Platelet mitochondrial respiration</other_name>
    <other_name>Serum presence of microparticles</other_name>
    <other_name>Serum presence of cardiolipin</other_name>
    <other_name>Functional independence measure</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples from which platelet function and platelet mitochondrial function will be
      analyzed, as well as serum markers for mitochondrial function
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The population will be geriatric patients with moderate to severe TBI (GCS &lt;=13).
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Traumatic brain injury with Glasgow Coma Scale Score (GCS) &lt;=13

        Exclusion Criteria:

        Previously know coagulation dysfunction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Susan Evans, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Carolinas Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Julia Raddatz</last_name>
    <phone>704-355-8287</phone>
    <email>julia.raddatz@carolinashealtcare.org</email>
  </overall_contact>
  <reference>
    <citation>Sillesen M, Rasmussen LS, Jin G, Jepsen CH, Imam A, Hwabejire JO, Halaweish I, DeMoya M, Velmahos G, Johansson PI, Alam HB. Assessment of coagulopathy, endothelial injury, and inflammation after traumatic brain injury and hemorrhage in a porcine model. J Trauma Acute Care Surg. 2014 Jan;76(1):12-9; discussion 19-20. doi: 10.1097/TA.0b013e3182aaa675.</citation>
    <PMID>24368352</PMID>
  </reference>
  <reference>
    <citation>Jokar TO, Khalil M, Rhee P, Kulvatunyou N, Pandit V, O'Keeffe T, Tang A, Joseph B. Ratio-based Resuscitation in Trauma Patients with Traumatic Brain Injury: Is There a Similar Effect? Am Surg. 2016 Mar;82(3):271-7.</citation>
    <PMID>27099065</PMID>
  </reference>
  <reference>
    <citation>Ortíz I, Velasco A, Le Borgne S, Revah S. Biodegradation of DDT by stimulation of indigenous microbial populations in soil with cosubstrates. Biodegradation. 2013 Apr;24(2):215-25. doi: 10.1007/s10532-012-9578-1. Epub 2012 Jul 31.</citation>
    <PMID>22847399</PMID>
  </reference>
  <reference>
    <citation>Nekludov M, Bellander BM, Blombäck M, Wallen HN. Platelet dysfunction in patients with severe traumatic brain injury. J Neurotrauma. 2007 Nov;24(11):1699-706.</citation>
    <PMID>18001200</PMID>
  </reference>
  <reference>
    <citation>Hukkelhoven CW, Steyerberg EW, Rampen AJ, Farace E, Habbema JD, Marshall LF, Murray GD, Maas AI. Patient age and outcome following severe traumatic brain injury: an analysis of 5600 patients. J Neurosurg. 2003 Oct;99(4):666-73. Review.</citation>
    <PMID>14567601</PMID>
  </reference>
  <reference>
    <citation>Zharikov S, Shiva S. Platelet mitochondrial function: from regulation of thrombosis to biomarker of disease. Biochem Soc Trans. 2013 Feb 1;41(1):118-23. doi: 10.1042/BST20120327. Review.</citation>
    <PMID>23356269</PMID>
  </reference>
  <reference>
    <citation>Reddoch KM, Pidcoke HF, Montgomery RK, Fedyk CG, Aden JK, Ramasubramanian AK, Cap AP. Hemostatic function of apheresis platelets stored at 4°C and 22°C. Shock. 2014 May;41 Suppl 1:54-61. doi: 10.1097/SHK.0000000000000082.</citation>
    <PMID>24169210</PMID>
  </reference>
  <reference>
    <citation>Stiegler G, Fischer G, Ramanathan G, Bencur P, Weigel G, Mannhalter C. P-selectin mRNA is maintained in platelet concentrates stored at 4 degrees C. Transfusion. 2009 May;49(5):921-7. doi: 10.1111/j.1537-2995.2008.02073.x. Epub 2009 Jan 21.</citation>
    <PMID>19175547</PMID>
  </reference>
  <reference>
    <citation>Nair PM, Pidcoke HF, Cap AP, Ramasubramanian AK. Effect of cold storage on shear-induced platelet aggregation and clot strength. J Trauma Acute Care Surg. 2014 Sep;77(3 Suppl 2):S88-93. doi: 10.1097/TA.0000000000000327.</citation>
    <PMID>25159368</PMID>
  </reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 6, 2017</study_first_submitted>
  <study_first_submitted_qc>June 8, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 9, 2017</study_first_posted>
  <last_update_submitted>June 8, 2017</last_update_submitted>
  <last_update_submitted_qc>June 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Brain Injuries, Traumatic</mesh_term>
    <mesh_term>Blood Platelet Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Only collaborators will have patient names for data acquisition.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

